Persistent Testosterone Suppression After Cessation of Androgen Deprivation Therapy for Prostate Cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jessica,Delgado

第一单位： Urology, University of Miami, Miami, USA.

作者： Jessica,Delgado ^[1] ; Jesse,Ory ^[2] ; Justin,Loloi ^[3] ; Nicholas A,Deebel ^[4] ; Ari,Bernstein ^[5] ; Sirpi,Nackeeran ^[6] ; Isaac,Zucker ^[7] ; Ranjith,Ramasamy ^[1]

作者单位： Urology, University of Miami, Miami, USA. ^[1] Urology, Dalhousie University, Halifax, CAN. ^[2] Urology, Montefiore Medical Center, New York, USA. ^[3] Urology, Atrium Health Wake Forest Baptist, Winston-Salem, USA. ^[4] Urology, New York University (NYU) Langone, New York, USA. ^[5] Medical Education, University of Miami Miller School of Medicine, Miami, USA. ^[6] Medicine, Florida International University, Miami, USA. ^[7]

关键词 antineoplastic agents hormonal hypogonadism prostate cancer testosterone

DOI 10.7759/cureus.32699

PMID 36686106

发布时间 2023-02-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cureus

2022年14卷12期

e32699页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Persistent Testosterone Suppression After Cessation of Androgen Deprivation Therapy for Prostate Cancer.

Cureus

相似文献

Cureus

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Persistent Testosterone Suppression After Cessation of Androgen Deprivation Therapy for Prostate Cancer.

Cureus

相似文献

Cureus

相关期刊

检索历史清除